ロード中...
Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not “immediate-response” TNF genes
BACKGROUND: TNF inhibitors have revolutionized the treatment of psoriasis vulgaris, as well as psoriatic and rheumatoid arthritis, and Crohns disease. Despite our understanding that these agents block TNF, their complex mechanism of action in disease resolution is still unclear. OBJECTIVE: To global...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2852188/ https://ncbi.nlm.nih.gov/pubmed/19895991 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2009.08.046 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|